CRIS

SEC source: 0001108205-25-000016 · wk-form4_1738271402.xml · derivative · entry 1

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 28, 2026 and as to an additional 6.25% of the original shares each successive quarter and until January 28, 2029.

SEC source: 0001108205-25-000012 · wk-form4_1738271260.xml · derivative · entry 1

KAITIN KENNETH I · CIK 0001271823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 1,600 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026.

SEC source: 0001108205-25-000008 · wk-form4_1738271120.xml · derivative · entry 1

Borgman Anne Elizabeth · CIK 0001886388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 1,600 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026.

SEC source: 0001108205-25-000010 · wk-form4_1738271192.xml · derivative · entry 1

Rubin Marc · CIK 0001412377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 1,600 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026.

SEC source: 0001108205-25-000006 · wk-form4_1738271021.xml · derivative · entry 1

Hohneker John · CIK 0001695378 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 1,600 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026.

SEC source: 0001108205-25-000004 · wk-form4_1738270939.xml · derivative · entry 1

GREENACRE MARTYN D · CIK 0001209727 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 1,600 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026.

SEC source: 0001108205-24-000055 · wk-form4_1716495126.xml · derivative · entry 1

Duvall Diantha · CIK 0001696784 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,000

Underlying: Common Stock · 39,000 shares

Expires 2034-01-18

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Compensation Committee of the Board of Directors of Curis, Inc. on January 19, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to, among other things, increase the number of shares authorized for issuance thereunder and increase the per participant limit on the number of shares subject to awards that can be granted annually to participants in the plan; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 19, 2025 and as to an additional 6.25% of the original shares each successive quarter and until January 19, 2028.

SEC source: 0001108205-24-000054 · wk-form4_1716495080.xml · derivative · entry 1

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-01-18

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Compensation Committee of the Board of Directors of Curis, Inc. on January 19, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to, among other things, increase the number of shares authorized for issuance thereunder and increase the per participant limit on the number of shares subject to awards that can be granted annually to participants in the plan; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 19, 2025 and as to an additional 6.25% of the original shares each successive quarter and until January 19, 2028.

SEC source: 0001108205-24-000053 · wk-form4_1716495039.xml · derivative · entry 1

Zung Jonathan B. · CIK 0001837972 · CDO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,700

Underlying: Common Stock · 40,700 shares

Expires 2034-01-18

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Compensation Committee of the Board of Directors of Curis, Inc. on January 19, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to, among other things, increase the number of shares authorized for issuance thereunder and increase the per participant limit on the number of shares subject to awards that can be granted annually to participants in the plan; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 19, 2025 and as to an additional 6.25% of the original shares each successive quarter and until January 19, 2028.

SEC source: 0001108205-24-000052 · wk-form4_1716495000.xml · derivative · entry 1

KAITIN KENNETH I · CIK 0001271823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,250

Underlying: Common Stock · 4,250 shares

Expires 2034-01-19

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025.

SEC source: 0001108205-24-000051 · wk-form4_1716494958.xml · derivative · entry 1

Rubin Marc · CIK 0001412377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,250

Underlying: Common Stock · 4,250 shares

Expires 2034-01-19

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025.

SEC source: 0001108205-24-000050 · wk-form4_1716494923.xml · derivative · entry 1

Borgman Anne Elizabeth · CIK 0001886388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,250

Underlying: Common Stock · 4,250 shares

Expires 2034-01-19

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025.

SEC source: 0001108205-24-000049 · wk-form4_1716494885.xml · derivative · entry 1

Hohneker John · CIK 0001695378 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,250

Underlying: Common Stock · 4,250 shares

Expires 2034-01-19

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025.

SEC source: 0001108205-24-000048 · wk-form4_1716494828.xml · derivative · entry 1

GREENACRE MARTYN D · CIK 0001209727 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,250

Underlying: Common Stock · 4,250 shares

Expires 2034-01-19

F1 · date: This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan.

F2 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025.

SEC source: 0001108205-23-000046 · wf-form4_168314471048406.xml · derivative · entry 1

Zung Jonathan B. · CIK 0001837972 · CDO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-04-30

F1 · derivative.exercise_date: This stock option vests over four years, with 25% of the original 500,000 shares underlying the award vesting on May 1, 2024 and an additional 6.25% of the original number of shares underlying the award vesting on each successive three-month period thereafter, subject to continued service.

SEC source: 0001108205-23-000016 · wf-form4_167459498699077.xml · derivative · entry 1

KAITIN KENNETH I · CIK 0001271823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2033-01-22

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 23, 2024), subject to the director's continued service with the Company.

SEC source: 0001108205-23-000015 · wf-form4_167459490789291.xml · derivative · entry 1

Hohneker John · CIK 0001695378 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2033-01-22

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 23, 2024), subject to the director's continued service with the Company.

SEC source: 0001108205-23-000013 · wf-form4_167459478956950.xml · derivative · entry 1

GREENACRE MARTYN D · CIK 0001209727 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2033-01-22

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 23, 2024), subject to the director's continued service with the Company.

SEC source: 0001108205-23-000014 · wf-form4_167459484097220.xml · derivative · entry 1

Rubin Marc · CIK 0001412377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2033-01-22

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 23, 2024), subject to the director's continued service with the Company.

SEC source: 0001108205-23-000012 · wf-form4_167459471417943.xml · derivative · entry 1

Borgman Anne Elizabeth · CIK 0001886388 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2033-01-22

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 23, 2024), subject to the director's continued service with the Company.

SEC source: 0001108205-23-000011 · wf-form4_167459462169459.xml · derivative · entry 1

Duvall Diantha · CIK 0001696784 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 20, 2024 and as to an additional 6.25% of the original shares each successive quarter and until January 20, 2027.

SEC source: 0001108205-23-000010 · wf-form4_167459436111911.xml · derivative · entry 1

Martell Robert · CIK 0001529922 · Head of Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 20, 2024 and as to an additional 6.25% of the original shares each successive quarter and until January 20, 2027.

SEC source: 0001108205-23-000009 · wf-form4_167459427200965.xml · derivative · entry 1

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2033-01-19

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 20, 2024 and as to an additional 6.25% of the original shares each successive quarter and until January 20, 2027.

SEC source: 0001209191-22-053658 · doc4.xml · derivative · entry 1

Borgman Anne Elizabeth · CIK 0001886388 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common stock · 25,000 shares

Expires 2032-10-11

F1 · derivative.exercise_price: Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on October 12, 2023, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on October 12, 2026, subject to Dr. Borgman's continued service on the Company's Board.

F1 · derivative.exercise_date: Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on October 12, 2023, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on October 12, 2026, subject to Dr. Borgman's continued service on the Company's Board.

SEC source: 0001209191-22-005691 · doc4.xml · derivative · entry 1

Rubin Marc · CIK 0001412377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common stock · 85,000 shares

Expires 2032-01-30

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company.

SEC source: 0001209191-22-005688 · doc4.xml · derivative · entry 1

KAITIN KENNETH I · CIK 0001271823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common stock · 85,000 shares

Expires 2032-01-30

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company.

SEC source: 0001209191-22-005689 · doc4.xml · derivative · entry 1

Kunkel Lori Anne · CIK 0001536368 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common stock · 85,000 shares

Expires 2032-01-30

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company.

SEC source: 0001209191-22-005686 · doc4.xml · derivative · entry 1

Hohneker John · CIK 0001695378 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common stock · 85,000 shares

Expires 2032-01-30

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company.

SEC source: 0001209191-22-005685 · doc4.xml · derivative · entry 1

GREENACRE MARTYN D · CIK 0001209727 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common stock · 85,000 shares

Expires 2032-01-30

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company.

SEC source: 0001209191-22-005651 · doc4.xml · nonDerivative · entry 2

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,877

F2 · kind: This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.

SEC source: 0001209191-22-005660 · doc4.xml · derivative · entry 1

Martell Robert · CIK 0001529922 · Head of Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,000

Underlying: Common stock · 252,000 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.

SEC source: 0001209191-22-005663 · doc4.xml · derivative · entry 1

Steinkrauss William · CIK 0001772403 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 360,000

Underlying: Common stock · 360,000 shares

Expires 2032-01-28

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.

SEC source: 0001209191-22-005651 · doc4.xml · derivative · entry 3

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 825,000

Underlying: Common stock · 825,000 shares

Expires 2032-01-28

F3 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 29, 2023 and as to an additional 6.25% of the original shares each successive quarter and until January 29, 2026.

SEC source: 0001209191-22-005651 · doc4.xml · nonDerivative · entry 1

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,971

F1 · kind: Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018.

SEC source: 0001209191-21-068030 · doc4.xml · derivative · entry 1

Hohneker John · CIK 0001695378 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common stock · 25,000 shares

Expires 2031-12-01

F1 · derivative.exercise_price: Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on December 2, 2022, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on December 2, 2025, subject to Dr. Hohneker's continued service on the Company's Board.

F1 · derivative.exercise_date: Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on December 2, 2022, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on December 2, 2025, subject to Dr. Hohneker's continued service on the Company's Board.

SEC source: 0001209191-21-006102 · doc4.xml · derivative · entry 1

GREENACRE MARTYN D · CIK 0001209727 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common stock · 33,000 shares

Expires 2031-01-27

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 28, 2022), subject to the director's continued service with the Company.

SEC source: 0001209191-21-006101 · doc4.xml · derivative · entry 1

Martell Robert · CIK 0001529922 · Head of Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,000

Underlying: Common stock · 126,000 shares

Expires 2031-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 28, 2022 and as to an additional 6.25% of the original shares each successive quarter and until January 28, 2025.

SEC source: 0001209191-21-006099 · doc4.xml · derivative · entry 1

Steinkrauss William · CIK 0001772403 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common stock · 180,000 shares

Expires 2031-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 28, 2022 and as to an additional 6.25% of the original shares each successive quarter and until January 28, 2025.

SEC source: 0001209191-21-006100 · doc4.xml · derivative · entry 1

Rubin Marc · CIK 0001412377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common stock · 33,000 shares

Expires 2031-01-27

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 28, 2022), subject to the director's continued service with the Company.

SEC source: 0001209191-21-006098 · doc4.xml · derivative · entry 1

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 330,000

Underlying: Common stock · 330,000 shares

Expires 2031-01-27

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on January 28, 2022 and as to an additional 6.25% of the original shares each successive quarter and until January 28, 2025.

SEC source: 0001209191-21-006097 · doc4.xml · derivative · entry 1

Kunkel Lori Anne · CIK 0001536368 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common stock · 33,000 shares

Expires 2031-01-27

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 28, 2022), subject to the director's continued service with the Company.

SEC source: 0001209191-21-006096 · doc4.xml · derivative · entry 1

KAITIN KENNETH I · CIK 0001271823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common stock · 33,000 shares

Expires 2031-01-27

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 28, 2022), subject to the director's continued service with the Company.

SEC source: 0001209191-21-005492 · doc4.xml · nonDerivative · entry 2

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,268

F2 · kind: This transaction was effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.

SEC source: 0001209191-21-005492 · doc4.xml · nonDerivative · entry 1

Dentzer James E · CIK 0001400977 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,362

F1 · kind: Shares were sold pursuant to a "sell to cover" arrangement to satisfy minimum statutory tax withholding obligations related to a vesting of a service-based restricted stock award granted on January 22, 2018.

SEC source: 0001209191-20-016251 · doc4.xml · derivative · entry 1

KAITIN KENNETH I · CIK 0001271823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common stock · 180,000 shares

Expires 2030-03-01

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (March 2, 2021), subject to the director's continued service with the Company.

SEC source: 0001209191-20-016247 · doc4.xml · derivative · entry 1

Kunkel Lori Anne · CIK 0001536368 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common stock · 180,000 shares

Expires 2030-03-01

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (March 2, 2021), subject to the director's continued service with the Company.

SEC source: 0001209191-20-016244 · doc4.xml · derivative · entry 1

Rubin Marc · CIK 0001412377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common stock · 180,000 shares

Expires 2030-03-01

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (March 2, 2021), subject to the director's continued service with the Company.

SEC source: 0001209191-20-016243 · doc4.xml · derivative · entry 1

GREENACRE MARTYN D · CIK 0001209727 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common stock · 180,000 shares

Expires 2030-03-01

F1 · derivative.exercise_date: Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (March 2, 2021), subject to the director's continued service with the Company.

SEC source: 0001209191-20-016240 · doc4.xml · derivative · entry 1

Steinkrauss William · CIK 0001772403 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 385,000

Underlying: Common stock · 385,000 shares

Expires 2030-03-01

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on March 2, 2021 and as to an additional 6.25% of the original shares each successive quarter and until March 2, 2024.

SEC source: 0001209191-20-016237 · doc4.xml · derivative · entry 1

Martell Robert · CIK 0001529922 · Head of Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 385,000

Underlying: Common stock · 385,000 shares

Expires 2030-03-01

F1 · derivative.exercise_date: The option grant described in this Form 4 filing vests as to 25% of the original shares on March 2, 2021 and as to an additional 6.25% of the original shares each successive quarter and until March 2, 2024.